SCHEMBL13901388

SCHEMBL13901388

Bc1cnc(Nc2cccc(NC(=O)C(N)Cc3ccccc3)c2)nc1NCCCO

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ULK1 O75385 3/20 0.43
▸ PDK1 Q15118 3/20 0.43
▸ ULK2 Q8IYT8 3/20 0.43
▸ MET P08581 3/20 0.42
▸ ALK Q9UM73 3/20 0.42
▸ TBK1 Q9UHD2 2/20 0.42
▸ EGFR P00533 4/20 0.42
▸ JAK3 P52333 1/20 0.42
▸ STAT6 P42226 1/20 0.41
▸ BTK Q06187 2/20 0.40
▸ ITK Q08881 1/20 0.40
▸ SYK P43405 1/20 0.40
▸ CIT O14578 1/20 0.40
▸ ROCK2 O75116 2/20 0.39
▸ ROCK1 Q13464 1/20 0.39
▸ AKT1 P31749 1/20 0.39
▸ MAP3K5 Q99683 1/20 0.39
▸ PDPK1 O15530 1/20 0.38
▸ NUAK1 O60285 1/20 0.38
▸ IKBKE Q14164 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13901511 0.93 TBK1 (0.46) ULK1PDK1ULK2METALK
SCHEMBL13901366 0.92 CCNT1 (0.44) ULK1PDK1ULK2METALK
SCHEMBL13901539 0.91 JAK3 (0.43) ULK1PDK1ULK2METALK
SCHEMBL13901493 0.90 MEN1 (0.41) ULK1PDK1ULK2METALK
SCHEMBL13898466 0.90 TBK1 (0.53) ULK1PDK1ULK2METALK
SCHEMBL13901597 0.89 NTRK1 (0.44) METALKTBK1EGFRJAK3
SCHEMBL13901471 0.89 MET (0.43) ULK1PDK1ULK2METALK
SCHEMBL13901594 0.88 BTK (0.45) METALKTBK1EGFRJAK3
SCHEMBL13901500 0.88 MET (0.41) ULK1PDK1ULK2METALK
SCHEMBL13901467 0.87 STAT6 (0.48) METALKTBK1EGFRJAK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7504410-B2 Chk-, Pdk- and Akt-inhibitory pyrimidines, their production and use as pharmaceutical agents SCHERING AKTIENGESELLSCHAFT (DE) 2009-03-17 — — US disclosed
Send feedback